Afficher la couverture 'T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients. | Poindron, Vincent' en grand format
/5

0 avis

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Archive ouverte

Poindron, Vincent | Chatelus, Emmanuel | Canuet, Matthieu | Gottenberg, Jacques Eric | Arnaud, Laurent | Gangi, Afshin | Gavand, Pierre-Edouard | Guffroy, Aurélien | Korganow, Anne-Sophie | Germain, Philippe | Sibilia, Jean | El Ghannudi, Soraya | Martin, Thierry

Edité par CCSD ; WB Saunders -

cardiac involvement is the second most frequent systemic sclerosis (SSc) related cause of death. It remains mostly asymptomatic in the early stage and is underdiagnosed with routine screening. Cardiac magnetic resonance imaging (CMR) could improve cardiac assessment of patients and noteworthily, new sequences allow the detection of diffuse myocardial fibrosis (DMF) by native T1 mapping. The aim of this study was to determine the prevalence of cardiac involvement by CMR native T1 mapping and its correlation with echocardiography data and non-cardiac manifestations in SSc patients.

Consulter en ligne

Suggestions

Du même auteur

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Archive ouverte | Scherlinger, Marc | CCSD

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

Archive ouverte | Felten, Renaud | CCSD

International audience. Background The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess t...

10 most important contemporary challenges in the management of SLE.

Archive ouverte | Felte, Renaud | CCSD

From a 1-year survival of less than 50% before the discovery of glucocorticoids to over 90% at 10 years in most dedicated centres, the spectrum of SLE has profoundly evolved. Despite this improvement, several major challenges curr...

Chargement des enrichissements...